Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function

Abstract Background Chronic kidney disease is associated with a high cardiovascular risk. Compared with glomerular filtration rate–matched CKD patients (CKDps), we previously reported a 2.7-fold greater risk of global mortality among kidney transplant recipients (KTRs). We then examined aortic stiffness [evaluated by carotid–femoral pulse wave velocity (CF-PWV)] and cardiovascular risk in KTRs compared with CKDps with comparable measured glomerular filtration rate (mGFR). Methods We analysed CF-PWV in two cohorts: TransplanTest (KTRs) and NephroTest (CKDps). Propensity scores were calculated including six variables: mGFR, age, sex, mean blood pressure (MBP), body mass index (BMI) and heart rate. After propensity score matching, we included 137 KTRs and 226 CKDps. Descriptive data were completed by logistic regression for CF-PWV values higher than the median (>10.6 m/s). Results At 12 months post-transplant, KTRs had significantly lower CF-PWV than CKDps (10.1 versus 11.0 m/s, P = 0.008) despite no difference at 3 months post-transplant (10.5 versus 11.0 m/s, P = 0.242). A lower occurrence of high arterial stiffness was noted among KTRs compared with CKDps (38.0% versus 57.1%, P < 0.001). It was especially associated with lower mGFR, older age, higher BMI, higher MBP, diabetes and higher serum parathyroid hormone levels. After adjustment, the odds ratio for the risk of high arterial stiffness in KTRs was 0.40 (95% confidence interval 0.23–0.68, P < 0.001). Conclusions Aortic stiffness was significantly less marked in KTRs 1 year post-transplant than in CKDps matched for GFR and other variables. This observation is compatible with the view that the pathogenesis of post-transplant cardiovascular disease differs, at least in part, from that of CKD per se.

[1]  C. Jacquelinet,et al.  Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Z. Massy,et al.  Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease , 2020, International journal of molecular sciences.

[3]  K. Petidis,et al.  Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke , 2019, International journal of hypertension.

[4]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[5]  J. Cameron,et al.  Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review , 2019, International journal of hypertension.

[6]  Z. Massy,et al.  Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation , 2018, Toxins.

[7]  E. Letavernier,et al.  From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients , 2018, PloS one.

[8]  A. Martínez‐Castelao,et al.  Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same? , 2017, Clinical kidney journal.

[9]  M. Briet,et al.  Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation , 2017, Journal of the American Heart Association.

[10]  G. Collins,et al.  Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance , 2017, BMC Medical Research Methodology.

[11]  Z. Massy,et al.  Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations? , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Z. Massy,et al.  Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[13]  S. Lekawanvijit Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[14]  Morten Wang Fagerland,et al.  Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients , 2015, Transplantation.

[15]  T. Wakatsuki,et al.  Impact of Indoxyl Sulfate, a Uremic Toxin, on Non-Culprit Coronary Plaque Composition Assessed on Integrated Backscatter Intravascular Ultrasound. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[16]  M. Hayashi,et al.  Plasma indoxyl sulfate and estimated glomerular filtration rate. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[17]  Yi Zhang,et al.  Pulse wave analysis with two tonometric devices: a comparison study , 2014, Physiological measurement.

[18]  Z. Massy,et al.  Clinical studies and chronic kidney disease: what did we learn recently? , 2014, Seminars in nephrology.

[19]  S. de Lusignan,et al.  Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study , 2013, PloS one.

[20]  J. Blacher,et al.  Aortic stiffness and cardiovascular risk in type 2 diabetes , 2013, Journal of hypertension.

[21]  J. Filipovský,et al.  Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. , 2012, Journal of hypertension.

[22]  M. Jadoul,et al.  Aortic Stiffness and Central Wave Reflections Predict Outcome in Renal Transplant Recipients , 2011, Hypertension.

[23]  A. Kribben,et al.  Pulse wave velocity predicts mortality in renal transplant patients , 2010, European journal of medical research.

[24]  P. Galan,et al.  Pulse wave velocity and vascular calcification at different stages of chronic kidney disease , 2010, Journal of hypertension.

[25]  Z. Massy,et al.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[26]  G. London,et al.  Assessment and significance of arterial stiffness in patients with chronic kidney disease , 2008, Current opinion in nephrology and hypertension.

[27]  M. Safar,et al.  Aortic stiffness of kidney transplant recipients correlates with donor age. , 2008, Journal of the American Society of Nephrology : JASN.

[28]  M. Stegall,et al.  Patient Survival and Cardiovascular Risk After Kidney Transplantation: The Challenge of Diabetes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  P. Houillier,et al.  Inter-method variability in PTH measurement: implication for the care of CKD patients. , 2006, Kidney international.

[30]  S. Laurent,et al.  Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. , 2006, Kidney international.

[31]  P. Houillier,et al.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  W. Winkelmayer,et al.  Patient and graft survival in older kidney transplant recipients: does age matter? , 2004, Journal of the American Society of Nephrology : JASN.

[33]  N. Aresté,et al.  Vascular calcification in the uremic patient: a cardiovascular risk? , 2003, Kidney international. Supplement.

[34]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension , 2003, Stroke.

[35]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[36]  G. London,et al.  Arterial structure and function in end-stage renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  D. Dunn,et al.  Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. , 2002, Kidney international.

[38]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[39]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[40]  J. Blacher,et al.  Impact of aortic stiffness on survival in end-stage renal disease. , 1999, Circulation.

[41]  D. Lorenz,et al.  Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. , 1998, Journal of the American Society of Nephrology : JASN.

[42]  J. Blacher,et al.  Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. , 1998, Hypertension.

[43]  S. Arend,et al.  Patient survival after renal transplantation; more than 25 years follow-up. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  B. Pannier,et al.  Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. , 1995, Hypertension.

[45]  R. Wolfe,et al.  Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  R. Wolfe,et al.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. , 1993, JAMA.

[47]  S. Tanomsup,et al.  Essential hypertension , 1935, Definitions.

[48]  M. Safar,et al.  Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness. , 2016, American journal of hypertension.

[49]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[50]  P. Houillier,et al.  Timing of onset of CKD-related metabolic complications. , 2009, Journal of the American Society of Nephrology : JASN.

[51]  R. Schmieder,et al.  Guidelines for management of arterial hypertension , 2007 .

[52]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[53]  A. Melk,et al.  Rethinking chronic allograft nephropathy: the concept of accelerated senescence. , 1999, Journal of the American Society of Nephrology : JASN.